Abstract
Preterm birth (PTB) is one of the main challenges in helathcare; it is the first cause of death of infants, while survivors face high chances of disability. Today, doctors have few ways to identify women at risk of premature birth; they are patients with either symptoms of delivery or a high-risk profile (such as previous preterm birth, short cervix, > 35 years of age, IVF pregnancies). However, half of the women who deliver prematurely fulfil NONE of these conditions. Such women are left with an undetected risk of preterm birth and thus higher chances of neonatal morbodoty and mortality. Our mission is to identify all women at risk of a premature birth so that all babies live up to their full potential!
Was ist das Besondere an diesem Projekt?
Rea develops a first of its kind diagnostic test, accessible for ALL pregnant women to frequently self-test their risk of a preterm birth with the latest technology. Rea's Smart Pad analyzes vaginal secretions of pregnant women for proteins indicative of birth and sends the test results to Rea's phone app.
Rea’s non-invasive technology would decrease the rates of preterm birth by allowing early detection; it would help doctors identify patients for medical interventions to delay delivery and to help mature the organs of the baby. Such early detection of preterm birth helps doctors prepare for optimal neonatal care and potentially decrease the time spent in the incubator, resulting in huge cost savings.
The InnoBooster grant will allow us to test the Smart Pad on pregnant women for the first time and will thus accelerate our market entry.
Stand/Resultate
None yet
Publikationen
None yet
Medienecho
Links
Am Projekt beteiligte Personen
Letzte Aktualisierung dieser Projektdarstellung 08.12.2020